BioWorld

Nov. 6, 2002

Senesco Plans $35M China Deal To Use Technology In Agriculture

Senesco Technologies Inc. is negotiating an exclusive deal outside the U.S. that would generate $35 million for the New Brunswick, N.J.-based company. (BioWorld Today) Read More

CuraGen, Mitsubishi Enter Deal Around Schizophrenia Targets

Hemoglobin Iron Dwindles As Old Age Pushes On; Heme Deficiency Also Assails Alzheimer's Patients

GeoVax Prepares For Trials Of AIDS Vaccine Candidate

Other News To Note

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for Dec. 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 11, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

DEE-lightful: Praxis’ phase II results allow stock to flex its muscle

BioWorld

Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...

Illustration of head with maze that is missing parts

CTAD 2025: The challenges of combination therapies for dementia

BioWorld Science

At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...